Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Assets (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Return on Assets for 15 consecutive years, with 0.03% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 4.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Dec 2025, up 4.0%, and an annual FY2025 reading of 0.03%, up 4.0% over the prior year.
  • Return on Assets was 0.03% for Q4 2025 at Amicus Therapeutics, down from 0.02% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.02% in Q3 2025 and bottomed at 0.35% in Q2 2022.
  • Average Return on Assets over 5 years is 0.21%, with a median of 0.25% recorded in 2023.
  • The sharpest move saw Return on Assets fell -6bps in 2022, then increased 16bps in 2025.
  • Year by year, Return on Assets stood at 0.27% in 2021, then fell by -19bps to 0.32% in 2022, then surged by 38bps to 0.2% in 2023, then skyrocketed by 64bps to 0.07% in 2024, then soared by 58bps to 0.03% in 2025.
  • Business Quant data shows Return on Assets for FOLD at 0.03% in Q4 2025, 0.02% in Q3 2025, and 0.05% in Q2 2025.